From post

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , и . Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk, , , , , , , , , и 23 other автор(ы). Journal of medical genetics, 49 (8): 525–532 (2012)Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers, , , , , , , , , и 176 other автор(ы). Human mutation, 33 (4): 690–702 (2012)Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction, , , , , , , , , и 168 other автор(ы). Cancer research, 70 (23): 9742–9754 (2010)Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , и 76 other автор(ы). American journal of human genetics, 82 (4): 937–948 (2008)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), , , , , , , , , и 123 other автор(ы). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , и 180 other автор(ы). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (4): 645–657 (2012)Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , и 427 other автор(ы). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers, , , , , , , , , и 99 other автор(ы). Human molecular genetics, 20 (23): 4732–4747 (2011)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , и 169 other автор(ы). Human molecular genetics, 20 (16): 3304–3321 (2011)Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers, , , , , , , , , и 63 other автор(ы). Breast cancer research : BCR, 12 (6): R102 (2010)